- Market Realist•13 hours ago
The Vanguard PRIMECAP Fund Investor Shares has had a great 2016. YTD and in the one-year period, it has been the best performer among our 12 funds.
- Investor's Business Daily•14 hours ago
Biogen could add another $1 billion in 2017 sales if its myotonic dystrophy drug garners strong trials data by year's end, says an analyst.
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||76.64 x 400|
|Ask||78.99 x 400|
|Day's Range||77.44 - 78.69|
|52wk Range||67.88 - 88.16|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.44|
|Avg Vol (3m)||3,454,689|
|Dividend & Yield||2.04 (2.61%)|